CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Price to Sales (2021 - 2022)

Updated

CytoDyn's Price to Sales came in at 767.56 for fiscal Q4 2022 (quarter ended May 31, 2022), down 43.9% from the prior quarter.

Analysis

CytoDyn (CYDY) Price to Sales (2021 - 2022) Analysis & Trends

Going back to fiscal Q1 2022, CytoDyn's Price to Sales data covers 4 quarters.

  • Business Quant data shows CYDY's Price to Sales at 1367.58 (Q3 2022), 3220.95 (Q2 2022) and 21665.23 (Q1 2022) in the three fiscal quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 CytoDyn 274.70 Mn 274.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 767.56
Feb 28, 2022 1,367.58
Nov 30, 2021 3,220.95
Aug 31, 2021 21,665.23
API Access

CytoDyn Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CYDY&period=max&api_key=YOUR_API_KEY